Raymond J. Furey
CIK 1577899 · EVP, GC, CCO & Corp Sec · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.96M
Companies
3
Total Filings
27
Lifetime Open-Market Net
-$2.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | EVP, GC, CCO & Corp Sec | 50,936 | $38.50 | $1.96M | -$59.7K | 11 | 2026-06-22 |
| Keenova Therapeutics plc (MNK) Delisted | Chief Compliance Officer | 6,462 | $0.34 | $2.2K | -$2.68M | 11 | 2017-01-06 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | See Remarks | 37,629 | — | — | $0 | 2 | 2014-03-10 |
Recent Filings · Page 2 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-31 | RIGL | Grant (A) | +19,717 | $0 | EDGAR |
| 2024-03-01 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | RIGL | Grant (A) | +209,000 | $0 | EDGAR |
| 2017-01-06 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −242 | -$12.9K | EDGAR |
| 2017-01-04 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −102 | -$5.1K | EDGAR |
| 2016-01-05 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +2,104 | -$7.5K | EDGAR |
| 2015-01-06 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +929 | $0 | EDGAR |
| 2014-12-03 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +1,487 | -$85.6K | EDGAR |
| 2014-12-03 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +4,510 | $0 | EDGAR |
| 2014-09-12 | Keenova Therapeutics plc (MNK) Delisted | Sell (S) | −5,441 | -$467.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.